{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T01:34:39Z","timestamp":1789349679886,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2000,2]]},"DOI":"10.1054\/mehy.1999.0027","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T11:34:15Z","timestamp":1027683255000},"page":"236-238","source":"Crossref","is-referenced-by-count":23,"title":["Pathogenesis of anaemia in hyperparathyroidism"],"prefix":"10.1054","volume":"54","author":[{"given":"A.","family":"Sikole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1054\/mehy.1999.0027_RF1","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1001\/archinte.1977.03630170020008","article-title":"Anaemia in primary hyperparathyroidism","volume":"137","author":"Boxer","year":"1977","journal-title":"Arch Intern Med"},{"key":"10.1054\/mehy.1999.0027_RF2","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/archinte.1976.03630080029010","article-title":"Primary hyperparathyroidism and anaemia","volume":"136","author":"Falko","year":"1976","journal-title":"Arch Intern Med"},{"key":"10.1054\/mehy.1999.0027_RF3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00005792-197403000-00002","article-title":"Primary hyperparathyroidism: clinical and biochemical features","volume":"53","author":"Mallette","year":"1974","journal-title":"Medicine"},{"key":"10.1054\/mehy.1999.0027_RF4","first-page":"204","article-title":"Pathogenesis of the anaemia of uremia: role of secondary hyperparathyroidism","volume":"24","author":"Massry","year":"1983","journal-title":"Kidney Int"},{"key":"10.1054\/mehy.1999.0027_RF5","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1001\/archinte.1978.03630360038018","article-title":"Anaemia and secondary hyperparathyroidism","volume":"138","author":"Zingraff","year":"1978","journal-title":"Arch Intern Med"},{"key":"10.1054\/mehy.1999.0027_RF6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ki.1989.18","article-title":"the anaemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin","volume":"35","author":"Eschbach","year":"1989","journal-title":"Kidney Int"},{"key":"10.1054\/mehy.1999.0027_RF7","doi-asserted-by":"crossref","first-page":"5558","DOI":"10.1016\/S0021-9258(19)63387-9","article-title":"Purification of human erythropoietin","volume":"252","author":"Miyake","year":"1977","journal-title":"J Biol Chem"},{"key":"10.1054\/mehy.1999.0027_RF8","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/313806a0","article-title":"Isolation and characterisation of genomic and cDNA clones of human erythropoietin","volume":"313","author":"Jacobs","year":"1985","journal-title":"Nature"},{"key":"10.1054\/mehy.1999.0027_RF9","series-title":"Erythropoietin: Molecular Physiology and Clinical Application","article-title":"Is erythropoietin a differentiation factor, a mitotic factor, or a survival factor?","author":"Bondurant","year":"1993"},{"key":"10.1054\/mehy.1999.0027_RF10","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1126\/science.2326648","article-title":"Erythropoietin retards DNA breakdown and prevents programmed death in erythroid cells","volume":"248","author":"Koury","year":"1990","journal-title":"Science"},{"key":"10.1054\/mehy.1999.0027_RF11","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1182\/blood.V77.6.1228.1228","article-title":"Erythropoietin is both a mitogen and a survival factor","volume":"77","author":"Spivak","year":"1991","journal-title":"Blood"},{"key":"10.1054\/mehy.1999.0027_RF12","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1172\/JCI110154","article-title":"Effect of parathyroid hormone on erythropoiesis","volume":"67","author":"Meytes","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1054\/mehy.1999.0027_RF13","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1172\/JCI110505","article-title":"Effect of parathyroid hormone on osmotic fragility of human erythrocytes","volume":"69","author":"Bogin","year":"1982","journal-title":"J Clin Invest"},{"key":"10.1054\/mehy.1999.0027_RF14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000417906","article-title":"Rheology in whole blood and in red blood cells under recombinant human erythropoietin therapy","volume":"76","author":"Lerche","year":"1989","journal-title":"Contrib Nephrol"},{"key":"10.1054\/mehy.1999.0027_RF15","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1681\/ASN.V781178","article-title":"Is erythropoietin a survival factor for the red blood cells?","volume":"7","author":"Polenakovic","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1054\/mehy.1999.0027_RF16","article-title":"One year of rhuEPO therapy prolongs RBC survival and may stabilize RBC membranes despite natural progression of chronic renal failure to uremia and need for dialysis","author":"Schwartz","year":"1990","journal-title":"ASAIO Trans M692,"},{"key":"10.1054\/mehy.1999.0027_RF17","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1365-2141.1990.tb02661.x","article-title":"Subcutaneous administration of recombinant human erythropoietin to subjects on continuous ambulatory peritoneal dialysis: an erythrokinetic assessment","volume":"75","author":"Hughes","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1054\/mehy.1999.0027_RF18","first-page":"502","article-title":"Calcitriol enhances the effect of Rh-Epo on erythroid differentiation","volume":"20","author":"Magocsi","year":"1997","journal-title":"Int J Artificial Organs"},{"key":"10.1054\/mehy.1999.0027_RF19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJM199301213280304","article-title":"Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia","volume":"328","author":"Rao","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1054\/mehy.1999.0027_RF20","first-page":"449","article-title":"Erythropoietic levels in uremic nephric and anephric patients","volume":"93","author":"Caro","year":"1979","journal-title":"J Lab Clin Med"},{"key":"10.1054\/mehy.1999.0027_RF21","first-page":"674","article-title":"Human recombinant erythropoietin does not induce bone marrow fibrosis in haemodialysed patients","volume":"4","author":"Tulliez","year":"1989","journal-title":"Nephrol Dial Transplant"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987799900270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987799900270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T07:09:51Z","timestamp":1621148991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987799900270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,2]]}},"alternative-id":["S0306987799900270"],"URL":"https:\/\/doi.org\/10.1054\/mehy.1999.0027","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2000,2]]}}}